Showing 1 - 4 results of 4 for search '"ИНДЕКС ПОЛЕЗНОСТИ ДЛЯ ЗДОРОВЬЯ"', query time: 0.53s Refine Results
  1. 1
  2. 2
    Academic Journal

    Source: Kachestvennaya Klinicheskaya Praktika = Good Clinical Practice; № 1 (2015); 92-98 ; Качественная клиническая практика; № 1 (2015); 92-98 ; 2618-8473 ; 2588-0519

    File Description: application/pdf

    Relation: https://www.clinvest.ru/jour/article/view/12/12; Inzucchi S.E., Bergenstal R.M., Buse J.B. et al. Management of Hyperglycemia in Type 2 Diabetes: A Patient-Centered Approach. Diabetes Care. 2012; 35(6): 1364-1379.; Дедов И.И., Шестакова М.В. Оптимизация и интенсификация инсулинотерапии при сахарном диабете 2 типа (клинические рекомендации). Сахарный диабет. 2010; 5: 9-16.; Колбин А.С. Фармакоэкономика базально-болюсной инсулинотерапии сахарного диабета 2 типа. Практическая фармакоэкономика. Эндокринология (научный сборник) Под ред. Р.У Хабриева. 2011, ООО Издательство «Р-Врач»: 67-75.; Майоров А.Ю., Мельникова О.Г. Клинические и психологические аспекты гипогликемии при сахарном диабете. Сахарный диабет. 2010;(3):46-50.; Davis R.E., Morrissey M., Peters J.R. et al. Impact of hypoglycaemia on quality of life and productivity in type 1 and type 2 diabetes. Curr Med Res Opin. 2005; 21(9):1477-1483.; Henderson J.N., Allen K.V., Deary I.J. et al. Hypoglycaemia in insulin-treated Type 2 diabetes: frequency, symptoms and impaired awareness. Diabet Med.2003;20(12):1016-1021.; Новик А.А., Ионова Т.И. Руководство по исследованию качества жизни в медицине (3-еизд., перераб. идополненное), под ред. академика РАМНЮ.Л. Шевченко. М.: РАЕН, 2012.; Ягудина Р.И., Куликов А.Ю., Литвиненко М.М. QALY: история, методология и будущее метода. Фармакоэкономика. 2010; 3 (1): 7-11.; Methods for the Analysis of Costs and Cost-Effectiveness in Randomized Studies [Электронный ресурс]. URL: http://www.ispor.org/OpenSourceIndex/ cached/www.uphs.upenn.edu/dgimhsr/costgrnt.PDF (дата обращения: 01.06.2012).; National Institute for Health and Clinical Excellence. Available from: www.nice.org.uk. [Accessed March 7, 2010]; Dawson D., Gravelle H., O’Mahony M., et al. Developing new approaches to measuring NHS outputs and productivity. Summary report// CHE Research Paper 6. York, UK: Center for Health Economics, The University of York.; Weinstein M.C., Torrance G., McGuire A., et al. QALY: Thebasics.ValueinHealth. 2009;12: 5-9.; Mehrez A., Gafni A. Quality-adjusted life years, utility theory, and healthy-years equivalents. Med Decis Making. 1989;9: 142-149.; American College of Physicians. Information on cost-effectiveness: an essential product of a national comparative effectiveness program. Ann Intern Med. 2008; 148: 956-961.; Erik Nord. The Person Trade-Off Approach to Valuing Health Care Programs, 1994.; Kaplan, Robert M. Utility assessment for estimating quality-adjusted life years. Valuing health care: Costs, benefits, and effectiveness of pharmaceuticals and other medical technologies. 1995; 31-60. Retrieved 2014-05-06.; Canadian Agency for Drugs and Technologies in Health. Guidelines for the economic evaluation of health technologies: Canada. 3rd. ed. Ottawa: The Agency; 2006.Available:>http://www.cadth.ca/media/pdf/186_EconomicGuidelines_e.pdf<< (accessed 2007 Feb 9).; Sullivan P. W., Ghushchyan V. Preference-based EQ-5D index scores for chronic conditions in the United States. Med Decis Making. 2006; 26(4): 410-420.; Fanshel S., Bush J.W. A health status index and its application to health service outcomes. Oper Res. 1970;18;1021-1066.; Brazier J., Usherwood T., Harper R., Thomas K. Deriving a preference-based single index from the UK SF-36 Health Survey. J ClinEpidemiol. 1998, 58: 1115-28.; Новик А.А., Ионова Т.И., Гандек Б. и др. Показатели качества жизни населения Санкт-Петербурга. Пробл. стандартизации в здравоохр. 2001. № 4: 22-31.; Clarke P., Gray A., Holman R. Estimating utility values for health states of type 2 diabetic patients using theEQ-5D (UKPDS 62). Med Decis Making. 2002; 22(4): 340-349.; Colquitt J.L., Green C., Sidhu M.K. et al. Clinical and cost effectiveness of continuous subcutaneous insulin infusion for diabetes. London (UK): National Institute of Clinical Excellence (NICE); 2002. Available: >>http://www.nice.org.uk/download.aspx?o=38421<< (accessed 2006 Sep 19).; Colquitt J.L., Green C., Sidhu M.K. et al. Clinical and cost-effectiveness of continuous subcutaneous insulin infusion for diabetes. Health Technol Assess (Winch Eng) 2004; 8(43).; Sullivan P.W., Lawrence W.F., Ghushchyan V. A national catalog of preference-based scores for chronic conditions in the United States. Med Care.2005; 43(7): 736-749.; Brazier J., Roberts J., Deverill M. The estimation of a preference-based measure of health from the SF-36.J Health Econ. 2002, 21: 271-292.; Brazier J.E., Roberts J. The estimation of a preference-based measure of health from the SF-12.Med Care2004, 42: 851-859.; Ferreira L.N., Ferreira P.L., Pereira L.N., Brazier J. An application of the SF-6D to create health values in Portuguese working age adults. J of Med Economics 2008, 11: 215-233.; Cruz L.N., Camey S.A., Hoffman J.F., Rowen D. Estimating the SF-6D value set for a population-based sample of Brazilians. Value in Health. 2011, 14: 108-114.; https://www.clinvest.ru/jour/article/view/12

  3. 3
  4. 4